Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abaloparatide
amgen
artificialintelligence
biotech
clinical trials
europe blog main
europe top stories
european commission
fda
life sciences
machinelearning
medical
national
national blog main
osteoporosis
radius health
regulation
romosozumab
san francisco blog main
san francisco top stories
teriparatide
ucb
What
approval
2
×
europe
amgen
amgen’s
analysis
based
carries
comparative
developed
devices
drug
european
health
heart
marketing
medicine
new
nod
osteoporosis
policy
raise
risk
usa
warning
wins
Language
unset
2
×
Current search:
europe���s
×
unset
×
approval
×
@LancetDigitalH
3 years ago
NEW Health Policy: 'Approval of #ArtificialIntelligence and #MachineLearning-based #medical devices in the USA and Europe (2015–20): a comparative analysis'. #regulation @Unispital_USZ @UZH_en https://bit.ly/38VsLsd https://t.co/EUTbZOqy8T
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning